health-austrade-logo.gif
   
Search     Click to Search
   
health-nav-health-over.gifhealth-nav-bio-over.gifhealth-nav-wellbeing-over.gif














Email Us
Enquiry form

PulmoSonix

PulmoSonix
 

Overview

PulmoSonix Pty Ltd aims to provide solutions for improved, objective and cost-effective clinical management of the respiratory patient. This involves bringing to market novel technologies which examine the acoustic response of the respiratory system, particularly focusing on the detection and analysis of normal and pathological breath sounds such as wheezes and cough, particularly in the asthmatic patient.

First to market will be three devices based on the WIM Platform.  The WIM family of products includes the WIM PC for use in primary care, paediatrics; asthma, allergy and occupational clinics, and in pulmonary function testing (PFT) laboratories; secondly, the Spiro-WIM™, will combine a spirometer and the WIM technology specifically for the assessment and management of Vocal Cord Dysfunction; and thirdly, the WIM-Nocturnal™, a wheeze, cough and respiration monitor for home and sleep-lab evaluation of asthma activity during a night sleep.

The WIM PC will be launched in Q4 of 2007.  Following the introduction of the first 3 members of the WIM family, two more products will be brought to market including the Personal Wheezometer™, a standalone miniature wheeze detector for home use; and the Acoustic Severe Asthma Monitor.

Business Opportunities (i.e Corporate Alliances/Partnerships)

We are seeking distributor opportunities in the Asia Pacific region.

Technology/Products and Services Description

The first medical device, the WIM PC will be launched in Q4 2007.  The WIM PC consists of a small pod containing signal conditioning electronics and an ambient noise microphone, essential in the defence against environmental noise interferences. Two Phonopneumography (PPG) breath sound sensors and a chest expansion belt for monitoring breathing activity connect the patient to the pod. The signals are digitised into a computer and analysis is performed using validated algorithms which automatically detect wheeze, cough and respiration activity.

Competitive Advantages

The WIM PC provides an objective and non-invasive measurement of wheeze rate in the asthmatic patient.  The device accurately detects wheeze, cough and respiration rate.  Being laptop computer based this technology provides the user with a familiar, easy to use operating environment.  Use of the device requires no physical effort on the part of the patient, making it suitable for those who cannot perform spirometry and during sleep.

Website address: www.karmelsonix.com


Health button - Request introduction     Health button - Back to Health B2B Portal

     

Austrade website | DFAT | Minister for TradePrivacy disclaimer | Technical info | Site disclaimer | Linking policy